This afternoon just before market close, Føroya Banki announced its 2025 net profit guidance range o...
Redeye provides a preview of CoinShares and updates its estimates ahead of the Q4 2024 report expect...
Redeye provides a brief comment on the final rights issue terms announced yesterday.
Redeye revisits some assumptions related to financing and likelihood of approval following the progr...
Ramlösa Shipping (”Ramlösa” eller ”Bolaget”) meddelade den 27 januari att bolaget blir delägare i Ca...
Redeye gives its preview on OssDsign’s Q3 2024 report, due on February 4.
Q4 is another solid quarter with 44% organic growth (CER), 6-7% above expectations.
Redeye leaves a comment following OncoZenge’s announcement yesterday of having entered a SEK30.
We estimate 2024 net profit of DKK 310m, at the upper end of the recently updated 2024 guidance rang...
Inför Q4-rapporten räknar Analysguiden med en svagare efterfrågan, särskilt inom industrisegmentet, ...
With the directed issue of units amounting to SEK 35m, supplemented by SEK 20m in loans, Nanexa secu...
Exposure to fast-growing and non-cyclical infrastructure We forecast 23% EBITA CAGR in '23-'26e, ~40...
Minor estimate changes Contract cancellations to carry negative impact on Q4 Trading at NTM EV/EBITA...
Announces some preliminary Q4 figures due to rights issue Sales SEK 8.
Ahead of NoHo's Q4 2024 report, due out 12 February, we tweak our estimates.
